New study finds out why Omicron variant is highly transmissible : The Tribune India

New study finds out why Omicron variant is highly transmissible

Says Omicron mutations increase the infectivity of SARS-CoV-2 virus-like particles and decrease antibody neutralisation

New study finds out why Omicron variant is highly transmissible

Photo for representational purpose only. Reuters file

Washington, July 20

A study comparing four variants of SARS-CoV-2 shows how the Omicron variant is adept at entering cells and escaping neutralisation from existing vaccines or prior infection, potentially contributing to the variant’s high transmissibility.

Published in journal ‘Proceedings of the National Academy of Sciences’ (PNAS) on July 19, the study suggests that Omicron mutations increase the infectivity of SARS-CoV-2 virus-like particles and decrease antibody neutralisation.

Researchers examined the virus using virus-like particles (VLPs) that imitate the SARS-CoV-2 proteins’ structural characteristics. VLPs of the B.1, B.1.1, Delta, and Omicron variants were evaluated against antisera samples from 38 COVID-19 survivors, both vaccinated and unvaccinated, by Jennifer Doudna, Melanie Ott, and colleagues.

In contrast to the original B.1 strain, antisera from the same individual who had received two vaccinations were up to 15 times less effective at neutralising Omicron in vitro. Nevertheless, the in vitro neutralising activity against Omicron was significantly increased in sera from participants who had received a third mRNA vaccine within 16 to 21 days. The in vitro neutralising potency of four currently available monoclonal antibody therapies—casirivimab, imdevimab, sotrovimab, and bebtelovimab—was then assessed by the authors. They discovered that only bebtelovimab was significantly effective against Omicron.

According to the findings, the authors hypothesise that Omicron may be particularly contagious in part because it is a harder strain to neutralise. The researchers also found an existing monoclonal antibody that might in vitro neutralise the variation.

Effective vaccine and treatment development depends on an understanding of the molecular factors that influence severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral fitness. The advent of viral variations such as Delta and Omicron highlighted the need to evaluate infectivity and antibody neutralisation, although research on intact SARS-CoV-2 is being conducted slowly due to biosafety level 3 handling requirements.

The impact of mutations outside the S gene cannot be determined by lentiviruses pseudotyped with the SARS-CoV-2 spike (S) protein, despite the ability to assess S-mediated cell binding and entrance via the ACE2 and TMPRSS2 receptors (1, 2).

To overcome these obstacles, the researchers created SARS-CoV-2 virus-like particles (SC2-VLPs), which combine the S, N, M, and E structural proteins with messenger RNA (mRNA) that contains a packaging signal to generate RNA-loaded capsids that are capable of spike-dependent cell transduction (3).

This approach allowed for quick testing of SARS-CoV-2 structural gene variants for their impact on both infection efficiency and antibody or antiserum neutralisation. It correctly represents the impact of changes in structural proteins that are reported in infections with viral isolates. — ANI

Tribune Shorts


Top News

Shah rules out dialogue with Pak, says J&K poll after electoral rolls published

Shah rules out dialogue with Pak, says J&K poll after electoral rolls published

From terror to tourist hotspot: HM hails Modi

US envoy visits PoK, calls it ‘Azad J&K’

US envoy visits PoK, calls it 'Azad J&K'

No MEA reaction yet, had objected to another US official’s v...

Zelenskyy to PM: No talks till Russia returns annexed areas

Zelenskyy to PM: No talks till Russia returns annexed areas

Appreciates India’s aid, PM’s ‘no time for war’ comment


Cities

View All